Nanohole-Array Induced Metallic Molybdenum Selenide Nanozyme for Photoenhanced Tumor-Specific Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37713431.
- Also identified by DOI 10.1021/acsnano.3c05000.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deficient catalytic sensitivity to the tumor microenvironment is a major obstacle to nanozyme-mediated tumor therapy. Electron transfer is the intrinsic essence for a nanozyme-catalyzed redox reaction. Here, we developed a nanohole-array-induced metallic molybdenum selenide (<i>n-</i>MoSe<sub>2</sub>) that is enriched with Se vacancies and can serve as an electronic transfer station for cycling electrons between H<sub>2</sub>O<sub>2</sub> decomposition and glutathione (GSH) depletion. In a MoSe<sub>2</sub> nanohole array, the metallic phase reaches up to 84.5%, which has been experimentally and theoretically demonstrated to exhibit ultrasensitive H<sub>2</sub>O<sub>2</sub> responses and enhanced peroxidase (POD)-like activities for H<sub>2</sub>O<sub>2</sub> thermodynamic heterolysis. More intriguingly, plenty of delocalized electrons appear due to phase- and vacancy-facilitated band structure reconstruction. Combined with the limited characteristic sizes of nanoholes, the surface plasmon resonance effect can be excited, leading to the broad absorption spectrum spanning of <i>n-</i>MoSe<sub>2</sub> from the visible to near-infrared region (NIR) for photothermal conversion. Under NIR laser irradiation, metallic MoSe<sub>2</sub> is able to induce out-of-balance redox and metabolism homeostasis in the tumor region, thus significantly improving therapeutic effects. This study that takes advantage of phase and defect engineering offers inspiring insights into the development of high-efficiency photothermal nanozymes.
Medical subject headings
- Hydrogen Peroxide
- Molybdenum